Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study-Reference-Cited by-同舟云学术

Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study

Published:2018-02-21 Issue:6 Volume:73 Page:1651-1658
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Chandra Sharat¹²,Fukuda Tsuyoshi²³,Mizuno Kana³,Davies Stella M¹²,Teusink-Cross Ashley⁴,Tarin Rich¹,Marsh Rebecca A¹²,Vinks Alexander A²³,Mehta Parinda A¹²

Affiliation:

1. Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

2. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA

3. Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

4. Division of Pharmacy, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

Funder

Astellas Pharma US

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/6/1651/24804697/dky030.pdf

Reference38 articles.

1. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients;Barnes;Br J Haematol,2007

2. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective;Tomblyn;Biol Blood Marrow Transplant,2009

3. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients;Science;Pediatr Blood Cancer,2014

4. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality;Upton;Clin Infect Dis,2007

5. Aspergillosis in children with cancer: a 34-year experience;Abbasi;Clin Infect Dis,1999

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermittent micafungin dosing schedule in pediatric oncology patients - safe for Outpatient Parenteral Antimicrobial Therapy?;EJC Paediatric Oncology;2024-09

2. Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients;Pharmaceutics;2024-08-29

3. Micafungin twice-a-week for prophylaxis of invasive Aspergillus infections in children with acute lymphoblastic leukaemia: A controlled cohort study;International Journal of Antimicrobial Agents;2024-01

4. Assessment of micafungin dosage regimens against Candida spp. in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation;Journal of Chemotherapy;2023-05-15

5. Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study;Journal of Antimicrobial Chemotherapy;2021-12-22